Erratum to: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas
Journal article

Erratum to: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

  • 2006-2-24
Published in:
  • Breast Cancer Research. - Springer Science and Business Media LLC. - 2006, vol. 8, no. 1
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/251454
Statistics

Document views: 15 File downloads: